Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

25 trials with published results (15%)

Research Maturity

94 completed trials (56% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.6%

6 terminated out of 168 trials

Success Rate

94.0%

+7.4% vs benchmark

Late-Stage Pipeline

10%

16 trials in Phase 3/4

Results Transparency

27%

25 of 94 completed with results

Key Signals

25 with results94% success

Data Visualizations

Phase Distribution

145Total
Not Applicable (96)
Early P 1 (3)
P 1 (25)
P 2 (5)
P 3 (3)
P 4 (13)

Trial Status

Completed94
Recruiting32
Not Yet Recruiting14
Unknown9
Terminated6
Active Not Recruiting6

Trial Success Rate

94.0%

Benchmark: 86.6%

Based on 94 completed trials

Clinical Trials (168)

Showing 20 of 20 trials
NCT06506188Not ApplicableRecruiting

Leveraging Infant Visit PrEP INtegration & tasK Shifting to Improve Post-partum HIV Prevention in Malawi

NCT05968755Not ApplicableRecruitingPrimary

Leveraging Chatbot to Improve PrEP in the Southern United States

NCT06745947Not ApplicableRecruitingPrimary

Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals

NCT06493357Not ApplicableRecruitingPrimary

Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmission of HIV in Malawi

NCT07829250Not ApplicableNot Yet RecruitingPrimary

Pharmacies in HIV Prevention: Fellowship, Fundamentals, and Sustainable Finances

NCT06820697Not ApplicableNot Yet RecruitingPrimary

Private-sector Access to Testing for Health Sustainability

NCT06864689Early Phase 1Not Yet RecruitingPrimary

Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.

NCT06566417CompletedPrimary

Social Media as a Risk Tool for HIV Prevention Needs

NCT06638892Not ApplicableRecruitingPrimary

Using PrEP, Doing It for Ourselves

NCT07218211Phase 4RecruitingPrimary

Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP

NCT03255915Early Phase 1Active Not RecruitingPrimary

PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study)

NCT06668363Not ApplicableCompleted

Enhancing HIV Prevention and Reducing Alcohol Use Among People Receiving STI Care in Lilongwe, Malawi

NCT07263048Not ApplicableNot Yet RecruitingPrimary

PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men

NCT06530225Not Yet RecruitingPrimary

Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program

NCT05804461Not ApplicableRecruitingPrimary

Optimizing Pre-Exposure Prophylaxis (PrEP) Among Latino Men Who Have Sex With Men (MSM) in Puerto Rico

NCT07510048Phase 2Not Yet Recruiting

Combatting HIV Or Other STIs Early (CHOOSE)

NCT07683117Not ApplicableRecruitingPrimary

PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)

NCT07133555Not ApplicableCompleted

Safe Spaces 4 Sexual Health

NCT05087680Not ApplicableCompletedPrimary

An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South

NCT07675629Phase 2Not Yet RecruitingPrimary

Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults

Scroll to load more

Research Network

Activity Timeline